Primary Care CKD Registry

This study examines whether a safety-net primary care CKD registry directed at the entire primary care team can enhance the delivery of guideline concordant CKD care, including BP control, ACEi/ARB use and albuminuria quantification.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Chronic Disease Chronic Kidney Diseases Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All PCPs who worked in practice teams and provided longitudinal primary care to patients were eligible to participate in this study. Practice teams that consisted of several physicians (+/- trainees), one nurse, nurse practitioners, medical assistants and behaviorists, were randomized 1:1 to one of two arms with a random number generator: access to an electronic CKD registry or a usual care registry for 12 months.

Exclusion criteria

PCPs who solely provided specialty care, for example HIV services or urgent care, were excluded.

Treatment and study plan

CKD Registry

Other

Health Service intervention

Primary outcomes

Change in clinic systolic

Time frame: 12 months

Change in ambulatory systolic BP measured at ambulatory clinic visits in the health care system.

Secondary outcomes

Change in proportion of patients with BP control

Time frame: 12 months

Change in the proportion of patients with BP control defined by BP <140/<90 mmHg at an ambulatory clinic visit.
Change in proportion fo patients with urine albuminuria quantification

Time frame: 12 months

Change in proportion of patients whose albuminuria was quantified by a urine test among those had not received quantification at trial initiation.
Change in albuminuria severity

Time frame: 12 months

Change in albuminuria severity (mg urine albumin/g urine creatinine) among those patients with albuminuria quantified at trial initiation
Change in proportion of patients with ACEi/ARB prescription

Time frame: 12 months

Change in proportion of patients prescribed an ACEi/ARB in the clinical record or had a documented reason for no prescription (i.e., allergy, prior development of hyperkalemia, or acute kidney injury)

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Registry information

Official study title

Impact of a Safety-Net Primary Care CKD Registry

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2015
First posted: Mar 22, 2018
Registry last updated: Mar 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed